X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (15) 15
middle aged (15) 15
aged (14) 14
female (14) 14
male (13) 13
adult (12) 12
lymphomas (9) 9
oncology (9) 9
prognosis (9) 9
aged, 80 and over (7) 7
hematology (7) 7
immunohistochemistry (6) 6
pathology (6) 6
treatment outcome (6) 6
adolescent (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
dlbcl (5) 5
hemic and lymphatic diseases (5) 5
kaplan-meier estimate (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
non-hodgkins-lymphoma (5) 5
rituximab (5) 5
b-cell lymphoma (4) 4
doxorubicin (4) 4
expression (4) 4
genetic aspects (4) 4
immune system diseases (4) 4
lymphoma, large b-cell, diffuse - mortality (4) 4
proportional hazards models (4) 4
transcriptome (4) 4
analysis (3) 3
biopsy (3) 3
cancer (3) 3
chemotherapy (3) 3
cyclophosphamide (3) 3
development and progression (3) 3
disease-free survival (3) 3
follow-up studies (3) 3
gene expression profiling (3) 3
health aspects (3) 3
lymphocytes (3) 3
lymphoma (3) 3
lymphoma, b-cell, marginal zone - pathology (3) 3
lymphoma, large b-cell, diffuse - genetics (3) 3
lymphoma, large b-cell, diffuse - pathology (3) 3
non-hodgkin's lymphomas (3) 3
proto-oncogene proteins c-myc - genetics (3) 3
survival (3) 3
tissue array analysis (3) 3
vincristine - administration & dosage (3) 3
young adult (3) 3
activation (2) 2
algorithms (2) 2
animals (2) 2
antimetabolites, antineoplastic - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
b-cell lymphomas (2) 2
bcl2 (2) 2
biomarkers, tumor - analysis (2) 2
bone marrow (2) 2
brain (2) 2
brain neoplasms - drug therapy (2) 2
brain neoplasms - immunology (2) 2
brain neoplasms - pathology (2) 2
c-myc (2) 2
cancer research (2) 2
care and treatment (2) 2
central nervous system (2) 2
central nervous system neoplasms - drug therapy (2) 2
central nervous system neoplasms - radiotherapy (2) 2
central-nervous-system (2) 2
cerebrospinal-fluid (2) 2
chronic disease (2) 2
clinical neurology (2) 2
combined modality therapy (2) 2
cyclophosphamide - administration & dosage (2) 2
diagnosis (2) 2
differentiation (2) 2
diffuse large b-cell lymphoma (2) 2
disease (2) 2
disease management (2) 2
doxorubicin - administration & dosage (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
drugs (2) 2
extranodal lymphomas (2) 2
gene expression (2) 2
gene rearrangement (2) 2
gene-expression (2) 2
helicobacter-pylori eradication (2) 2
hodgkin (2) 2
immunophenotyping (2) 2
in situ hybridization, fluorescence (2) 2
journal article (2) 2
lymphoma - drug therapy (2) 2
lymphoma - therapy (2) 2
lymphoma, b-cell, marginal zone - microbiology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Modern Pathology, ISSN 0893-3952, 2015, Volume 28, Issue 12, pp. 1555 - 1573
Journal Article
Modern Pathology, ISSN 0893-3952, 2015, Volume 28, Issue 10, pp. 1297 - 1314
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2013, Volume 160, Issue 1, pp. 47 - 52
Journal Article
Oncology, ISSN 0030-2414, 02/2001, Volume 60, Issue 2, pp. 134 - 140
Objectives: To assess the feasibility and the activity, as well as the efficacy to treat meninges, of chemotherapy (CHT) containing high-dose methotrexate... 
Clinical Study | Chemotherapy, intrathecal | Methotrexate, high dose | Brain lymphoma | Primary central nervous system lymphoma | Non-Hodgkin's lymphomas | Brain neoplasm | Meningeal lymphomatosis | PRIMARY CNS LYMPHOMA | SURVIVAL | DEXAMETHASONE | CYCLOPHOSPHAMIDE | brain neoplasm | DOXORUBICIN | PHASE-II | methotrexate, high dose | CEREBROSPINAL-FLUID | primary central nervous system lymphoma | RADIATION-THERAPY | brain lymphoma | meningeal lymphomatosis | chemotherapy, intrathecal | ONCOLOGY | NON-HODGKINS-LYMPHOMA | non-Hodgkin's lymphomas | BRAIN | Procarbazine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antimetabolites, Antineoplastic - administration & dosage | Central Nervous System Neoplasms - radiotherapy | Feasibility Studies | Antineoplastic Agents, Phytogenic - administration & dosage | Lymphoma - drug therapy | Meningeal Neoplasms - drug therapy | Vincristine - administration & dosage | Adult | Female | Lymphoma - radiotherapy | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Radiotherapy, Adjuvant | Drug Administration Schedule | Treatment Outcome | Brain Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Methotrexate - administration & dosage | Aged | Meningeal Neoplasms - radiotherapy | Central Nervous System Neoplasms - diagnosis | Central Nervous System Neoplasms - drug therapy
Journal Article
Annals of Hematology, ISSN 0939-5555, 4/2011, Volume 90, Issue 4, pp. 401 - 408
Journal Article
Journal Article